Skip to main content
. 2018 Aug 2;13(8):e0201535. doi: 10.1371/journal.pone.0201535

Fig 4.

Fig 4

Percent population attributable risk (%PAR) of end-stage renal disease associated with percent changes in eGFR during the (a) 2-year or (b) 3-year baseline period.